Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John W. Devlin, Pharm.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
education and training
University of Toronto, Toronto CanadaBScPharm1988Pharmacy
London Health Sciences Center, London Canada1989Pharmacy Practice Residency
University of Toronto, Toronto CanadaPharmD1996Phamacy
Henry Ford Hospital, Detroit MI1997Fellowship Critical Care Research
awards and honors
2020
Masters Critical Care Medicine

Overview
overview
John Devlin is a Professor of Pharmacy at Northeastern University and an Associate Scientist in the Division of Pulmonary and Critical Care Medicine at Brigham and Women's Hospital, Boston, MA. His federally funded research program, focused on the detection, prevention and treatment of delirium and disrupted sleep in the ICU, as well as the epidemiology of medication-associated delirium and polypharmacy during and after critical illness, has generated nearly three million in funding and more than 200 publications. He is a member of the editorial boards of Critical Care Medicine and Pharmacotherapy, a past president of the American Delirium Society, and chaired the SCCM 2018 pain, agitation, delirium, immobility and disrupted sleep international clinical practice guidelines.
keywords

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R21AHQR8480441001 (Andrea Sikora) Jul 1, 2022 - Jun 30, 2024
    AHRQ
    Use of machine learning models for medication regimen complexity to predict critical care pharmacist resources
    Role Description: The goal of this study is to train machine learning models to predict critical care pharmacist staffing resources to reduce adverse drug events and improve other outcomes in critically adults
    Role: Co-Investigator
  2. 2022P000213 (John Devlin) May 1, 2022 - Apr 30, 2024
    Sedana Medical
    A Phase 3, Multicenter, Randomized, Controlled, Open-Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients
    Role Description: The goal of the study is to evaluate the safety and efficacy of inhaled isoflurane when administered vis the Sedana ACD-S device for sedation in mechanically ventilated medical critically ill adults.
    Role: PI
  3. 2020A018257 (John Devlin) Aug 23, 2021 - Apr 1, 2022
    BioExcel Pharmaceuticals
    A phase 2, multicenter, randomized, double-blind, placebo-controlled, ascending starting dose finding, safety, and efficacy study of BXCL501 in agitation associated with delirium in ICU patients.
    Role Description: To evaluate the dose, safety and efficacy of a new sub-buccal film tab formulation of dexmedetomidine for the treatment of delirium in critically ill adults.
    Role: PI
  4. R13185760 (John Devlin and Jan Whitehead Busby) Apr 1, 2021 - Mar 31, 2025
    NIA
    The Network for Investigation of Delirium: Unifying Scientists (NIDUS) 9th to 13th Annual Delirium Bootcamps: a foundation for future exploration.
    Role Description: The goal of this conference award is to to formally train and mentor junior investigators interested in conducting research surrounding delirium.
    Role: MPI
  5. R33HL23452 (Sharon Inouye) Apr 1, 2021 - Mar 31, 2025
    NIA
    NIDUS II: Advanced-stage development and utilization of the NIDUS research infrastructure to advance interdisciplinary aging research in delirium.
    Role Description: The goal of this collaborative network to advance scientific research on the causes, mechanisms, outcomes, diagnosis, prevention, and treatment of delirium in older adults.
    Role: Co-Investigator

Featured Content
Twitter

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Updating...
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Devlin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (500)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.